Hungary rejects the EU’s Pfizer COVID vaccine deal, opting instead to use vaccines from China and Russia.
According to the Associated Press, Hungary has opted out of a COVID-19 vaccine deal that the European Union has with the United States.
Instead, Hungary is relying on Chinese and Russian vaccines, as well as previously obtained Western shots. Hungary has the second-highest vaccination rate in Europe, with almost 40% of the population having already received one dose of the vaccine.
Hungary opted not to participate in the latest purchasing deal, which followed previous deals with the two firms for 600 million shots, despite EU nations agreeing to continue their policy of buying doses jointly.
See the list below for further Associated Press reporting.
Except for Hungary, the EU’s executive arm finalized a third vaccine deal with Pfizer and BioNTech on Thursday for an additional 1.8 billion doses of their COVID-19 shot to share among the bloc’s countries through 2023.
Following a meeting with regional health ministers, EU Health Commissioner Stella Kyriakides said, “It [Hungary] will not be protected by the deal.” “Under the new deal, all other member states will be able to buy vaccines.”
According to the European Commission, the deal, which was reached on behalf of all 27 EU countries earlier this month, would enable the purchase of 900 million doses of current vaccines as well as a serum tailored to the virus’ variants, with an option to buy an additional 900 million doses.
The new agreement was signed less than a week before a court hearing in Brussels pitting the Commission against AstraZeneca, a pharmaceutical corporation accused by the EU of not delivering the promised amount of doses of its own vaccine.
The agreement with Pfizer-BioNTech, according to the Commission, requires that doses be manufactured in the EU and that critical components be sourced locally.
The Commission said, “From the start of the supply in 2022, delivery to the EU is assured.”
The deal between AstraZeneca and the EU called for an initial 300 million doses to be distributed among EU member countries, with an option for another 100 million. The doses were supposed to be sent all year, but only 30 million were sent in the first quarter. According to the Commission, the company is set to provide only 70 million doses in. This is a brief summary.